Literature DB >> 21762938

Myocardial remodeling with aortic stenosis and after aortic valve replacement: mechanisms and future prognostic implications.

William M Yarbrough1, Rupak Mukherjee, John S Ikonomidis, Michael R Zile, Francis G Spinale.   

Abstract

Aortic valve stenosis is a common cause of left ventricular pressure overload, a pathologic process that elicits myocyte hypertrophy and alterations in extracellular matrix composition, both of which contribute to increases in left ventricular stiffness. However, clinical and animal studies suggest that increased myocardial extracellular matrix fibrillar collagen content occurs later in the time course of left ventricular pressure overload at a time coincident with severe abnormalities in diastolic function followed by the development of symptomatic heart failure. Aortic valve replacement remains the most effective treatment for elimination of chronic pressure overload secondary to aortic stenosis but has traditionally been recommended only after the onset of clinical symptoms. Long-term follow-up of patients with symptomatic aortic stenosis after aortic valve replacement suggests that valve replacement may not result in complete reversal of the maladaptive changes that occur within the myocardial extracellular matrix secondary to the pressure overload state. To the contrary, residual left ventricular extracellular matrix abnormalities such as these are likely responsible for persistent abnormalities in diastolic function and increased morbidity and mortality after aortic valve replacement. Defining the mechanisms and pathways responsible for regulating the myocardial extracellular matrix during the natural history of aortic stenosis may provide a means by which to detect crucial structural milestones and thereby permit more precise identification of the development of maladaptive left ventricular remodeling. Published by Mosby, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21762938      PMCID: PMC3210937          DOI: 10.1016/j.jtcvs.2011.04.044

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  56 in total

1.  Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease.

Authors:  S Hinan Ahmed; Leslie L Clark; Weems R Pennington; Carson S Webb; D Dirk Bonnema; Amy H Leonardi; Catherine D McClure; Francis G Spinale; Michael R Zile
Journal:  Circulation       Date:  2006-04-24       Impact factor: 29.690

2.  Activation of apoptotic caspase cascade during the transition to pressure overload-induced heart failure.

Authors:  Narain Moorjani; Manzoor Ahmad; Pedro Catarino; Robin Brittin; Danyah Trabzuni; Futwan Al-Mohanna; Navneet Narula; Jagat Narula; Stephen Westaby
Journal:  J Am Coll Cardiol       Date:  2006-09-12       Impact factor: 24.094

3.  Involvement of cardiotrophin-1 in cardiac myocyte-nonmyocyte interactions during hypertrophy of rat cardiac myocytes in vitro.

Authors:  K Kuwahara; Y Saito; M Harada; M Ishikawa; E Ogawa; Y Miyamoto; I Hamanaka; S Kamitani; N Kajiyama; N Takahashi; O Nakagawa; I Masuda; K Nakao
Journal:  Circulation       Date:  1999-09-07       Impact factor: 29.690

4.  C-reactive protein is increased in patients with degenerative aortic valvular stenosis.

Authors:  A Galante; A Pietroiusti; M Vellini; P Piccolo; G Possati; M De Bonis; R L Grillo; C Fontana; C Favalli
Journal:  J Am Coll Cardiol       Date:  2001-10       Impact factor: 24.094

5.  Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms.

Authors:  Stefan Hein; Eyal Arnon; Sawa Kostin; Markus Schönburg; Albrecht Elsässer; Victoria Polyakova; Erwin P Bauer; Wolf-Peter Klövekorn; Jutta Schaper
Journal:  Circulation       Date:  2003-02-25       Impact factor: 29.690

6.  Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial.

Authors:  Richard B Devereux; Björn Dahlöf; Eva Gerdts; Kurt Boman; Markku S Nieminen; Vasilios Papademetriou; Jens Rokkedal; Katherine E Harris; Jonathan M Edelman; Kristian Wachtell
Journal:  Circulation       Date:  2004-08-23       Impact factor: 29.690

7.  Tissue inhibitor of metalloproteinases levels in patients with chronic heart failure: an independent predictor of mortality.

Authors:  S Frantz; S Störk; K Michels; M Eigenthaler; G Ertl; J Bauersachs; C E Angermann
Journal:  Eur J Heart Fail       Date:  2008-03-17       Impact factor: 15.534

8.  Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats.

Authors:  Fumitaka Kuwahara; Hisashi Kai; Keisuke Tokuda; Mamiko Kai; Akira Takeshita; Kensuke Egashira; Tsutomu Imaizumi
Journal:  Circulation       Date:  2002-07-02       Impact factor: 29.690

9.  Serum markers of collagen type I metabolism in spontaneously hypertensive rats: relation to myocardial fibrosis.

Authors:  J Díez; A Panizo; M J Gil; I Monreal; M Hernández; J Pardo Mindán
Journal:  Circulation       Date:  1996-03-01       Impact factor: 29.690

10.  Association of plasma cardiotrophin-1 with stage C heart failure in hypertensive patients: potential diagnostic implications.

Authors:  Begoña López; Arantxa González; Ramón Querejeta; Joaquín Barba; Javier Díez
Journal:  J Hypertens       Date:  2009-02       Impact factor: 4.844

View more
  30 in total

Review 1.  Myocardial Interstitial Fibrosis in Nonischemic Heart Disease, Part 3/4: JACC Focus Seminar.

Authors:  Javier Díez; Arantxa González; Jason C Kovacic
Journal:  J Am Coll Cardiol       Date:  2020-05-05       Impact factor: 24.094

2.  B-type natriuretic peptide as a biochemical marker of left ventricular diastolic function: assessment in asymptomatic patients 1 year after valve replacement for aortic stenosis.

Authors:  Vito Mannacio; Anita Antignano; Vincenzo De Amicis; Luigi Di Tommaso; Raffaele Giordano; Gabriele Iannelli; Carlo Vosa
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-05-08

3.  Predictors of improvement in diastolic function after transcatheter aortic valve implantation.

Authors:  Konigstein Maayan; Biner Simon; Topilsky Yan; Abramowitz Yigal; Havakuk Ofer; Ben-Assa Eyal; Leshem-Rubinow Eran; Arbel Yaron; Keren Gad; Banai Shmuel; Finkelstein Ariel
Journal:  J Echocardiogr       Date:  2013-11-14

4.  Loss of dystrophin is associated with increased myocardial stiffness in a model of left ventricular hypertrophy.

Authors:  Martín Donato; Bruno Buchholz; Celina Morales; Laura Valdez; Tamara Zaobornyj; Sergio Baratta; Diamela T Paez; Mirian Matoso; Guillermo Vaccarino; Demian Chejtman; Oscar Agüero; Juan Telayna; José Navia; Alejandro Hita; Alberto Boveris; Ricardo J Gelpi
Journal:  Mol Cell Biochem       Date:  2017-03-18       Impact factor: 3.396

5.  Patterns of left ventricular remodeling in aortic stenosis: therapeutic implications.

Authors:  Sammy Elmariah
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-07

6.  Left ventricular remodeling and improvement in diastolic function after balloon aortic valvuloplasty for congenital aortic stenosis.

Authors:  Kevin G Friedman; Doff B McElhinney; Steven D Colan; Diego Porras; Andrew J Powell; James E Lock; David W Brown
Journal:  Circ Cardiovasc Interv       Date:  2012-06-26       Impact factor: 6.546

Review 7.  Clinical Implications of Serum Biomarkers of Cardiac Stress in Aortic Stenosis.

Authors:  Nimesh Patel; Dharam J Kumbhani
Journal:  Curr Heart Fail Rep       Date:  2018-10

8.  Progressive induction of left ventricular pressure overload in a large animal model elicits myocardial remodeling and a unique matrix signature.

Authors:  William M Yarbrough; Rupak Mukherjee; Robert E Stroud; William T Rivers; J Marshall Oelsen; Jennifer A Dixon; Shaina R Eckhouse; John S Ikonomidis; Michael R Zile; Francis G Spinale
Journal:  J Thorac Cardiovasc Surg       Date:  2011-11-04       Impact factor: 5.209

9.  Predictions of hypertrophy and its regression in response to pressure overload.

Authors:  Kyoko Yoshida; Andrew D McCulloch; Jeffrey H Omens; Jeffrey W Holmes
Journal:  Biomech Model Mechanobiol       Date:  2019-12-07

Review 10.  Biomechanics of Cardiac Function.

Authors:  Andrew P Voorhees; Hai-Chao Han
Journal:  Compr Physiol       Date:  2015-09-20       Impact factor: 9.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.